Dasatinib - CISMeF

Preferred Label : Dasatinib;

MeSH definition : A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.;

MeSH synonym : N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide;

MeSH hyponym : BMS 354825; sprycel; (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; 354825, BMS; BMS354825; BMS-354825;

MeSH Related Number : 302962-49-8 (dasatinib);

Wikipedia link : https://en.wikipedia.org/wiki/Sprycel;

Is substance : O;

UNII : RBZ1571X5H;

Details

Origin ID

D000069439;

UMLS CUI

C1455147;

ATC code(s)
- dasatinib [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Dasatinib [NCIt concept]
- Dasatinib (substance) [SNOMED CT concept]
Exact mapping(s) to DCI
- dasatinib monohydrate [International Nonproprietary Name]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
- protein kinase inhibitors [MeSH Descriptor]
Record concept(s)
- (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide [MeSH concept]
- BMS 354825 [MeSH concept]
- dasatinib [MeSH concept]
- sprycel [MeSH concept]
Related MeSH Supplementary Concept(s)
- UM-164 [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Dasatinib [NCIt concept]
- Dasatinib (substance) [SNOMED CT concept]
- Product containing dasatinib (medicinal product) [SNOMED CT concept]
- dasatinib [Substance BNPC]
- dasatinib [ATC Code]
- dasatinib monohydrate [International Nonproprietary Name]
Validated automatic mappings to BTNT
- dasatinib monohydrate [International Nonproprietary Name]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients